Macter International Limited (PSX:MACTER)
358.40
-8.29 (-2.26%)
At close: Nov 11, 2025
Macter International Market Cap
Macter International has a market cap or net worth of 16.42 billion as of November 11, 2025. Its market cap has increased by 183.10% in one year.
Market Cap
16.42B
Enterprise Value
17.00B
Revenue
10.96B
Ranking
n/a
PE Ratio
19.68
Stock Price
358.40
Market Cap Chart
Since September 25, 2017, Macter International's market cap has increased from 3.37B to 16.42B, an increase of 387.29%. That is a compound annual growth rate of 21.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2025 | 16.42B | 11.47% |
| Dec 31, 2024 | 14.73B | 265.38% |
| Dec 21, 2023 | 4.03B | -11.96% |
| Dec 28, 2022 | 4.58B | -9.14% |
| Dec 30, 2021 | 5.04B | -15.67% |
| Dec 31, 2020 | 5.98B | 80.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 126.87B |
| Abbott Laboratories (Pakistan) | 108.02B |
| The Searle Company | 64.26B |
| Highnoon Laboratories | 58.62B |
| AGP Limited | 54.63B |
| Shifa International Hospitals | 32.30B |
| Citi Pharma | 18.87B |
| Ferozsons Laboratories | 17.38B |